Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -81.60% | 563.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -81.60% | 563.26% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -81.60% | 563.26% | |||
| SG&A Expenses | -13.77% | -20.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.81% | 38.61% | |||
| Operating Income | -39.79% | -15.03% | |||
| Income Before Tax | -44.48% | -18.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -44.48% | -18.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -44.48% | -18.27% | |||
| EBIT | -39.79% | -15.03% | |||
| EBITDA | -40.14% | -15.12% | |||
| EPS Basic | -42.85% | -18.18% | |||
| Normalized Basic EPS | -42.86% | -18.22% | |||
| EPS Diluted | -43.17% | -17.74% | |||
| Normalized Diluted EPS | -42.86% | -18.22% | |||
| Average Basic Shares Outstanding | 1.14% | 0.06% | |||
| Average Diluted Shares Outstanding | 1.14% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||